Technology

Illumina expands Billion Cell Atlas program with new AI drug developers

Illumina expands Billion Cell Atlas program with new AI drug developers

Partners will use unprecedented data scale to advance more precise medicines to approval SAN DIEGO, July 16, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that the Billion Cell Atlas alliance has added three new member companies, includin…

Read Full Article

This article was originally published on PRNewswire. Click the button above to read the complete article.